BlackRock’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

BlackRock’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-429	Closed	-$6K	–	5991
2022 Q2	$6K	Hold	429	–	–	﹤0.01%	5675
2022 Q1	$7K	Sell	429 -1,248	-74%	-$21.1K	﹤0.01%	5662
2021 Q4	$36K	Sell	1,677 -2,351	-58%	-$59.8K	﹤0.01%	5463
2021 Q3	$119K	Buy	4,028 +1,095	+37%	+$33K	﹤0.01%	5099
2021 Q2	$86K	Buy	2,933 +29	+1%	+$905	﹤0.01%	5095
2021 Q1	$93K	Buy	+2,904	New	+$97.8K	﹤0.01%	4844

Other funds holding ZEAL

TimeScale Financial Danvers, Massachusetts $463M AUM 12.48% 1-Year Est. Return

BlackRock's ZEAL Position: Q3 2022 in Review

BlackRock sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2022, closing a stake of 429 shares — an estimated $6K sold.

BlackRock first reported a position in ZEAL in Q1 2021 and held it in 6 quarters. The position peaked at $119K in Q3 2021. 1 fund tracked by Wall St. Rank holds ZEAL as of Q3 2022.

BlackRock reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2022 after selling out during the quarter.
BlackRock sold 429 Zealand Pharma A/S American Depositary Shares shares in Q3 2022, an estimated $6K.
BlackRock first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2021 and held it in 6 quarters.
BlackRock's Zealand Pharma A/S American Depositary Shares position peaked at $119K in Q3 2021.
1 fund tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2022.

Based on BlackRock's 13F filing for Q3 2022, filed 14 Nov 2022.